Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.714
+0.009 (1.21%)
At close: Feb 21, 2025, 4:00 PM
0.736
+0.022 (3.08%)
After-hours: Feb 21, 2025, 7:53 PM EST
Vaxart Employees
Vaxart had 109 employees as of December 31, 2023. The number of employees decreased by 55 or -33.54% compared to the previous year.
Employees
109
Change (1Y)
-55
Growth (1Y)
-33.54%
Revenue / Employee
$153,761
Profits / Employee
-$663,651
Market Cap
162.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
VXRT News
- 5 weeks ago - Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial - GlobeNewsWire
- 2 months ago - Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - GlobeNewsWire
- 3 months ago - Vaxart, Inc. (VXRT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - GlobeNewsWire
- 6 months ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside - Benzinga
- 7 months ago - Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript - Seeking Alpha